ArticleACR open rheumatology2023
Health Care Providers' Experiences of a Mandatory Nationwide Transition to an Adalimumab Biosimilar.
Chiara Gasteiger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it